Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.
DISCUSSION: In summary, treatment of RBCs with PIPA prior to RCE elicited favourable or neutral changes in key metabolic and vascular biomarkers. Further study of its efficacy and safety is recommended and could ultimately serve to improve outcomes in chronically transfused SCD patients.
PMID: 32203007 [PubMed - as supplied by publisher]
Source: Blood Transfusion - Category: Hematology Authors: Lopez Domowicz DA, Welsby I, Esther CR, Zhu H, Marek RD, Lee G, Shah N, Poisson JL, McMahon TJ Tags: Blood Transfus Source Type: research
More News: Blood Transusion | Clinical Trials | Eyes | Food and Drug Administration (FDA) | Hematology | Organic | Sickle Cell Anemia | Study | Transfusion Therapy